Skip to content
AXON

AXON ENTERPRISE, INC.

AXON ENTERPRISE, INC. Q3 FY2024 earnings call

November 7, 2024 · fiscal period ended 2024-09

EPS · actual vs est

$1.45 / $1.20Beat +20.8%

Revenue · actual vs est

$544.3M / $525.3MBeat +3.6%
Ask about this call

Summary

Generated 2024-11-07

Management highlights

  • Product Innovation Focus: Emphasis on AI with the AI Era plan, TASER 10 combined with VR training, real-time capabilities with Axon Body 4 and Fusus, and momentum in drones/robotics via Dedrone acquisition.
  • Strong Financial Performance: Q3 revenue grew 32% year-over-year, adjusted EBITDA margin 26.7%. Record bookings in Q3 exceeding $1 billion, with strength across state and local, federal, international, justice, and enterprise segments.
  • Customer-Centric Approach: Focus on putting customers first, seen through interactions at events like AUSA and IACP, and the week of the customer initiative.
View in transcript ↓

Segment performance

TASER: Revenue grew 36% year-over-year, with TASER 10 driving growth due to increased capacity and broad-based demand. Cloud and services: Up 36% year-over-year, with software revenue as the primary driver; ARR of $885 million up 36% year-over-year, net revenue retention at 123%. Sensors and other: Up 18% year-over-year, with strong demand for Axon Body 4 partially offset by Fleet. Revenue contribution % wasn't explicitly stated for each segment, but each segment contributed to the overall 32% year-over-year revenue growth.

View in transcript ↓

Guidance

  • Raised Q4 2024 revenue guidance to $560 million to $570 million (over 30% growth at midpoint), full-year revenue ~$2.07 billion (32%+ annual growth).
  • Adjusted EBITDA guidance for Q4: $130 million to $135 million (23.5% margin), full-year adjusted EBITDA ~$510 million (24.6% margin).
  • Confidence in 25% margin target for 2025, showing leverage over 2024.
View in transcript ↓

Risks

  • Political uncertainties impacting opportunities in certain regions.
  • Potential tariffs affecting supply chain components and requiring flexibility in sourcing.
  • Execution risks related to integrating acquisitions like Dedrone and managing associated costs.
View in transcript ↓

Q&A highlights

Q: Update on Draft One pipeline and pricing?

A: Draft One pipeline continues to grow, especially post-IACP, with interest in the AI Era bundle. Draft One alone is $65/month with $20 transcription, AI Era bundle price $199, sum of parts ~$250-$350.

Q: Sustainability of TASER growth?

A: Confident TASER growth is sustainable due to TASER 10's fundamental leap in technology, goal to transition all T7 and legacy models to T10, and strong demand (2x pace of TASER 7).

Q: Bookings outlook for Q4 2024?

A: Confident Q4 will be a record bookings quarter, with strength across all segments (state and local, federal, international, enterprise) and visibility into large deals.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.45$1.20+20.8%
Revenue$544.3M$525.3M+3.6%

Transcript

November 7, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.